Ni Zhang

Jiangxi University of Traditional Chinese Medicine — China

Medicine · Health Sciences

23h-index2.1kcitations150works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Soft tissue tumors and treatment(8), Cancer Immunotherapy and Biomarkers(7), Lung Cancer Diagnosis and Treatment(7), Tuberous Sclerosis Complex Research(6), Vascular Tumors and Angiosarcomas(6)

Publications150 total

One Blow To Obtain Integrated Information on Metals, NO, and Metabolites in Breath Gas by Mass Spectrometry
Analytical Chemistry·2026
Puerariae Lobatae Radix: Botanical Traits, Chemical Constituents, and Anti-Metabolic Disease Effects-A Review
Acupuncture and Herbal Medicine·2026Open Access
(±)-odoriferols A–E, five pairs of enantiomeric flavonoids and benzofurans from Dalbergia odorifera with anti-inflammatory activity
Phytochemistry·2026
Metabolomics and Network Pharmacology Reveal Metabolic Differences and Action Mechanisms of <i>Prunella vulgaris</i> Antioxidant Metabolites in Guizhou, China
Chemistry & Biodiversity·2026Open Access
Histone Deacetylase Inhibitor Entinostat Exerts Anti-NSCLC Effects Through the EGFR Signaling Pathway and MDM2-p53 Axis
Current Pharmaceutical Biotechnology·2026
Additional file 1 of CCL14, identified by multi-omics approach, serves as a novel indicator of disease severity and progression in lymphangioleiomyomatosis
Figshare·2026Open Access
Additional file 3 of CCL14, identified by multi-omics approach, serves as a novel indicator of disease severity and progression in lymphangioleiomyomatosis
Figshare·2026Open Access
Additional file 3 of CCL14, identified by multi-omics approach, serves as a novel indicator of disease severity and progression in lymphangioleiomyomatosis
Figshare·2026Open Access
Additional file 1 of CCL14, identified by multi-omics approach, serves as a novel indicator of disease severity and progression in lymphangioleiomyomatosis
Figshare·2026Open Access
Additional file 2 of CCL14, identified by multi-omics approach, serves as a novel indicator of disease severity and progression in lymphangioleiomyomatosis
Figshare·2026Open Access
Additional file 2 of CCL14, identified by multi-omics approach, serves as a novel indicator of disease severity and progression in lymphangioleiomyomatosis
Figshare·2026Open Access
Unveiling the power of PARP inhibitors: a meta-analysis on newly diagnosed advanced ovarian cancer maintenance therapy
Expert Review of Anticancer Therapy·2025
Echoes of the struggle with cancer: cognitive impairment in Chinese children
BMC Cancer·2025Open Access
CLCF1 is associated with perineurial invasion and prognosis in colorectal cancer
Scientific Reports·2025Open Access
Evaluation of the sustainability and resilience of rooftop agrivoltaics based on the WFE–C–Cost model
Sustainable Cities and Society·2025
Pathways between activity behaviors, emotional distress, and subjective cognitive impairment in middle-aged and older breast cancer patients receiving chemotherapy: a cross-sectional study
European Journal of Oncology Nursing·2025
A new self-normalized forecast comparison test
Economics Letters·2025
Estimating the vegetable yield and carbon reduction benefits of urban agriculture in Fuzhou based on planting intensity
Sustainable Cities and Society·2025
Advanced cholangiocarcinoma with human epidermal growth factor receptor 2 (HER2) amplification treated with Trastuzumab deruxtecan (T-DXd): A case report
Medicine·2025· 1 citedOpen Access
Network relationships among depressive symptoms, sleep quality, and frailty in Chinese older adults: an undirected and bayesian network analysis
BMC Geriatrics·2025· 1 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Xiangning Fu(5), Yixin Cai(3), Taoyu Chen(3), Zubin Ye(3), Kunneng Jiang(3), Zhiqian Lin(3), Qunyue Liu(3), Zi Ye(2), Chunyan Wu(2), Qingfeng Wang(2), Xinyue Huang(2), Liping Du(2), Qingfeng Cao(2), Jihong Tang(2), Chunjiang Zhou(2), Qian Xu(2), Xiong Xiao(2), Aize Kijlstra(2), Nan Qin(2), Peizeng Yang(2)